Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury
- 31 July 1994
- journal article
- Published by Elsevier BV in American Heart Journal
- Vol. 128 (1), 1-6
- https://doi.org/10.1016/0002-8703(94)90002-7
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Increased production of angiotensin II in the adrenal gland of stroke-prone spontaneously hypertensive rats with malignant hypertensionBiochemical and Biophysical Research Communications, 1991
- Nonpeptide Angiotensin II Receptor AntagonistsAmerican Journal of Hypertension, 1990
- Angiotensin II: Hemodynamic regulator or growth factor?Journal of Molecular and Cellular Cardiology, 1990
- Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis.Circulation Research, 1989
- Preliminary biochemical characterization of two angiotensin II receptor subtypesBiochemical and Biophysical Research Communications, 1989
- Relationships between structure and effects of ACE inhibitors: comparative effects in myocardial ischaemic/reperfusion injury.British Journal of Clinical Pharmacology, 1989
- Angiotension converting enzyme inhibitors and ischaemic heart diseaseEuropean Heart Journal, 1988
- Determination of mechanisms of myocardial ischemic injury by 31P-MRS effect of cathecholamine on ischemic heartsBiochemical and Biophysical Research Communications, 1988
- Antihypertensive Action of a Non-Sulfhydryl Angiotensin Converting Enzyme Inhibitor (CV-3317) in Various Hypertensive ModelsThe Japanese Journal of Pharmacology, 1986
- Inhibition of Angiotensin Converting Enzyme by CV-3317, a Non-Sulfhydryl CompoundThe Japanese Journal of Pharmacology, 1986